News Updates
More Articles
- Benefits of Integrating Patient Engagement with Diversity, Equity, and Inclusion in New Medical Product Development: A Call for Action
- Drug Shortages in the Global South: A Proposed Parallel Tech and Reg Transfer Framework
- Fair Pay for Patient Engagement: Navigating the Evolving Landscape of Remuneration
- Industry’s Window to Express Interest in Africa Continental Product Evaluation Pilot Closes End of February 2024
- The Importance of Regulatory Due Diligence During the Acquisition Process
DIA Global Annual Meeting 2021: When Can You Trust Real-World Evidence for Decision-Making?
One of the unexpected impacts of the social isolation and distancing policies mandated during the COVID-19 pandemic has been growing interest in the use of real-world evidence (RWE), as an alternative or a complement to evidence provided by traditional randomized clinical trials (RCTs), for regulatory review and approval of therapeutic products.
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!